These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 8939154)

  • 1. Induction of IgE antibodies in mice and rhesus monkeys with recombinant birch pollen allergens: different allergenicity of Bet v 1 and Bet v 2.
    Vrtala S; Mayer P; Ferreira F; Susani M; Sehon AH; Kraft D; Valenta R
    J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 1):913-21. PubMed ID: 8939154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel, and oak pollen: a quantitative IgE inhibition study with sera from different populations.
    Niederberger V; Pauli G; Grönlund H; Fröschl R; Rumpold H; Kraft D; Valenta R; Spitzauer S
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):579-91. PubMed ID: 9802365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral immune responses to recombinant tree pollen allergens (Bet v I and Bet v II) in mice: construction of a live oral allergy vaccine.
    Vrtala S; Grote M; Ferreira F; Susani M; Stocker B; Kraft D; Valenta R
    Int Arch Allergy Immunol; 1995; 107(1-3):290-4. PubMed ID: 7613152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of IgE antibodies with predefined specificity in rhesus monkeys with recombinant birch pollen allergens, Bet v 1 and Bet v 2.
    Ferreira FD; Mayer P; Sperr WR; Valent P; Seiberler S; Ebner C; Liehl E; Scheiner O; Kraft D; Valenta R
    J Allergy Clin Immunol; 1996 Jan; 97(1 Pt 1):95-103. PubMed ID: 8568143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fagales pollen sensitization in a birch-free area: a respiratory cohort survey using Fagales pollen extracts and birch recombinant allergens (rBet v 1, rBet v 2, rBet v 4).
    Mari A; Wallner M; Ferreira F
    Clin Exp Allergy; 2003 Oct; 33(10):1419-28. PubMed ID: 14519150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin testing with recombinant allergens rBet v 1 and birch profilin, rBet v 2: diagnostic value for birch pollen and associated allergies.
    Pauli G; Oster JP; Deviller P; Heiss S; Bessot JC; Susani M; Ferreira F; Kraft D; Valenta R
    J Allergy Clin Immunol; 1996 May; 97(5):1100-9. PubMed ID: 8626988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System.
    Movérare R; Elfman L; Vesterinen E; Metso T; Haahtela T
    Allergy; 2002 May; 57(5):423-30. PubMed ID: 11972482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergens from birch pollen and pollen of the European chestnut share common epitopes.
    Hirschwehr R; Jäger S; Horak F; Ferreira F; Valenta R; Ebner C; Kraft D; Scheiner O
    Clin Exp Allergy; 1993 Sep; 23(9):755-61. PubMed ID: 10779306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How far can we simplify in vitro diagnostics for Fagales tree pollen allergy? A study with three whole pollen extracts and purified natural and recombinant allergens.
    Van Ree R; Van Leeuwen WA; Akkerdaas JH; Aalberse RC
    Clin Exp Allergy; 1999 Jun; 29(6):848-55. PubMed ID: 10336603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of allergens in fruits and vegetables: IgE cross-reactivities with the important birch pollen allergens Bet v 1 and Bet v 2 (birch profilin).
    Ebner C; Hirschwehr R; Bauer L; Breiteneder H; Valenta R; Ebner H; Kraft D; Scheiner O
    J Allergy Clin Immunol; 1995 May; 95(5 Pt 1):962-9. PubMed ID: 7751517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1.
    Mahler V; Vrtala S; Kuss O; Diepgen TL; Suck R; Cromwell O; Fiebig H; Hartl A; Thalhamer J; Schuler G; Kraft D; Valenta R
    Clin Exp Allergy; 2004 Jan; 34(1):115-22. PubMed ID: 14720271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies.
    Vrtala S; Akdis CA; Budak F; Akdis M; Blaser K; Kraft D; Valenta R
    J Immunol; 2000 Dec; 165(11):6653-9. PubMed ID: 11086111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different profiles in specific IgE to rBet v 1 and rBet v 2 in patients allergic to birch pollen from six countries.
    Elfman L; Svensson M; Lidholm J; Pauli G; Valenta R
    Int Arch Allergy Immunol; 1997; 113(1-3):249-51. PubMed ID: 9130537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of specific IgE antibodies in the sera of patients allergic to birch pollen using recombinant allergens Bet v 1, Bet v 2, Bet v 4: evaluation of different IgE reactivity profiles.
    Rossi RE; Monasterolo G; Monasterolo S
    Allergy; 2003 Sep; 58(9):929-32. PubMed ID: 12911423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of genetically engineered hypoallergenic rBet v 1 derivatives with rBet v 1 wild-type by skin prick and intradermal testing: results obtained in a French population.
    Pauli G; Purohit A; Oster JP; De Blay F; Vrtala S; Niederberger V; Kraft D; Valenta R
    Clin Exp Allergy; 2000 Aug; 30(8):1076-84. PubMed ID: 10931114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning of the minor allergen Api g 4 profilin from celery (Apium graveolens) and its cross-reactivity with birch pollen profilin Bet v 2.
    Scheurer S; Wangorsch A; Haustein D; Vieths S
    Clin Exp Allergy; 2000 Jul; 30(7):962-71. PubMed ID: 10848918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reacting allergens in tree pollen and pollen-related food allergy: implications for diagnosis of specific IgE.
    Scheiner O; Aberer W; Ebner C; Ferreira F; Hoffmann-Sommergruber K; Hsieh LS; Kraft D; Sowka S; Vanek-Krebitz M; Breiteneder H
    Int Arch Allergy Immunol; 1997; 113(1-3):105-8. PubMed ID: 9130495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning and characterization of a birch pollen minor allergen, Bet v 5, belonging to a family of isoflavone reductase-related proteins.
    Karamloo F; Schmitz N; Scheurer S; Foetisch K; Hoffmann A; Haustein D; Vieths S
    J Allergy Clin Immunol; 1999 Nov; 104(5):991-9. PubMed ID: 10550744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic engineering of trimers of hypoallergenic fragments of the major birch pollen allergen, Bet v 1, for allergy vaccination.
    Vrtala S; Fohr M; Campana R; Baumgartner C; Valent P; Valenta R
    Vaccine; 2011 Mar; 29(11):2140-8. PubMed ID: 21215346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season.
    van Hage-Hamsten M; Kronqvist M; Zetterström O; Johansson E; Niederberger V; Vrtala S; Grönlund H; Grönneberg R; Valenta R
    J Allergy Clin Immunol; 1999 Nov; 104(5):969-77. PubMed ID: 10550741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.